High percentage of regulatory T cells before and after vitamin B12 treatment in patients with pernicious anemia [0.03%]
维生素B１２治疗前後恶性贫血患者调节性Ｔ细胞的高比例
Satoru Watanabe,Norifumi Ide,Hatsue Ogawara et al.
Satoru Watanabe et al.
Introduction: In some previous studies, vitamin B12 treatment showed immunomodulatory effects and restored the immunological abnormalities in patients with pernicious anemia (PA). In the present study, peripheral blood T ...
Is there a role for low-dose eltrombopag as maintenance therapy in the treatment of immune thrombocytopenia? [0.03%]
低剂量艾曲波帕作为免疫性血小板减少症维持治疗的作用探讨
Efthymia Vlachaki,Nikolaos Sousos,Vasilios Perifanis et al.
Efthymia Vlachaki et al.
Background/aim: Thrombopoietin receptor agonists (romiplostim and eltrombopag) have recently been licensed for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia (ITP) with an insufficient ...
Case Reports
Acta haematologica. 2015;133(1):78-82. DOI:10.1159/000361075 2015
Mesenchymal stromal cells as an adjuvant treatment for severe late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation [0.03%]
间充质基质细胞作为异基因造血干细胞移植后严重晚期出血性膀胱炎的辅助治疗
Ying Wang,Feng Chen,Bing Gu et al.
Ying Wang et al.
The management of severe late-onset hemorrhagic cystitis (LO-HC) after allogeneic hematopoietic stem cell transplantation (HSCT) is still challenging. Because mesenchymal stromal cells (MSCs) possess anti-inflammatory and tissue repair-prom...
Partow Kebriaei
Partow Kebriaei
Editorial
Acta haematologica. 2015;133(1):70-1. DOI:10.1159/000363644 2015
Nuriman Ozgunes,Yesim Oztas,Selma Unal et al.
Nuriman Ozgunes et al.
Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting [0.03%]
临床替扎司他治疗失败后的骨髓增生异常综合征和慢性单核细胞白血病后继发的急性髓系白血病预后不良
Pasquale Niscola,Andrea Tendas,Luca Cupelli et al.
Pasquale Niscola et al.
Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera [0.03%]
对JAK2阳性原发性血小板增多症和真性红细胞增多症中阿司匹林反应型、类似偏头痛的短暂脑缺血发作和眼缺血发作以及红斑综合征的一项研究
Jan Jacques Michiels,Zwi Berneman,Alain Gadisseur et al.
Jan Jacques Michiels et al.
Migraine-like cerebral transient ischemic attacks (MIAs) and ocular ischemic manifestations were the main presenting features in 10 JAK2(V617F)-positive patients studied, with essential thrombocythemia (ET) in 6 and polycythemia vera (PV) i...
Case Reports
Acta haematologica. 2015;133(1):56-63. DOI:10.1159/000360388 2015
Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera [0.03%]
BCR/ABL阳性的血小板增多症与BCR/ABL阴性的真性红细胞增多症和原发性血小板增多症的血小板增多症的临床和骨髓特点差异研究
Jan Jacques Michiels,Achille Pich,Hendrik De Raeve et al.
Jan Jacques Michiels et al.
Case Reports
Acta haematologica. 2015;133(1):52-5. DOI:10.1159/000358915 2015
Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond [0.03%]
从1950年Dameshek到2005年Vainchencker及其后的骨髓增生性疾患诊断标准的概念变化、分子病因及骨髓增殖性肿瘤的分类
Jan Jacques Michiels,Zwi Berneman,Wilfried Schroyens et al.
Jan Jacques Michiels et al.
The Polycythemia Vera Study Group (PVSG) and WHO classifications distinguished the Philadelphia (Ph(1)) chromosome-positive chronic myeloid leukemia from the Ph(1)-negative myeloproliferative neoplasms (MPN) essential thrombocythemia (ET), ...
Effect of vitamin D replacement on hemoglobin concentration in subjects with concurrent iron-deficiency anemia and vitamin D deficiency: a randomized, single-blinded, placebo-controlled trial [0.03%]
维生素D缺乏且合并缺铁性贫血者补充维生素D对血红蛋白浓度的影响：一项随机、单盲、安慰剂对照试验
Basavraj Sooragonda,Sanjay Kumar Bhadada,Viral N Shah et al.
Basavraj Sooragonda et al.
Background: The effect of vitamin D replacement on hemoglobin (Hb) concentration in subjects with concurrent deficiencies of vitamin D and iron is not known. ...
Clinical Trial
Acta haematologica. 2015;133(1):31-5. DOI:10.1159/000357104 2015